01

Stanford Medicine congratulates Stanford professor Jay Bhattacharya, MD, PhD, on his nomination to lead the National Institutes of Health.

Six-year-olds who were exposed prenatally to common antiseizure medications had normal verbal and cognitive abilities, a large, multisite study has found.

Researchers used a new screening technique to identify genes involved in heart cell damage during a common chemotherapy treatment. They also found a drug that may be able to prevent it.

New drug treats a rare heart disease, transthyretin amyloid cardiomyopathy, or ATTR-CM.

Mutations in a complex that helps proteins fold correctly are tied to developmental disorders that include seizures and intellectual disability, Stanford Medicine-led research has found.

Researchers used artificial intelligence to predict the activity of thousands of genes in tumors based on routinely collected images of tumor biopsies. It could guide treatment without costly genomic tests.

Stanford Medicine launches a pilot program collaboration to expand its CME courses to a broader audience worldwide, setting a new standard for online medical education.

CAR-T cells show promise against pediatric diffuse midline gliomas, brain and spinal cord tumors that are among the deadliest cancers, a Stanford Medicine trial found.

Why do some people develop severe flu symptoms? A Stanford Medicine study points the finger at an unsung portion of the antibodies our immune systems generate to fend off invading pathogens.

Tiny circles called ecDNA are critical in cancer development and drug resistance. An international Stanford Medicine-led team publishes landmark studies detailing new findings and potential therapies.